| |
Atherosclerosis is a fully electronic journal,
all manuscripts are to be submitted via the internet.
To submit your paper online, click on the link  http://ees.elsevier.com/ath/.
This will take you to the Atherosclerosis Editorial Manager home page. The Author Information box to the right of the
page provides relevant information, including a tutorial on how to submit your manuscript.
Authors must select an appropriate Associate
Editor from the list shown on the website, the expertise terms for each Editor are shown to assist with this choice. Authors must suggest
four potential reviewers for their paper and to avoid delay in processing your submission please ensure that email addresses given for
reviewers are correct. The Editorial Board reserves the right to decide whether or not the suggested reviewers are used. Please note
the Associate Editors will not act as reviewers. Authors may also indicate if a particular reviewer should not be approached.
Types of Paper
Types of papers that can be submitted for consideration by the Editorial Board include:
a) Basic Research Papers reporting results of original research or investigation using in vitro, cell culture, or animal models.
Basic Research Papers should not exceed 4000 words (including tables and legends to figures) and no more than 30 references.
b) Clinical Research Papers reporting results of original clinical research or investigation in human subjects. Clinical Research
Papers should not exceed 4000 words (including tables and legends to figures) and no more than 30 references.
Basic
and Clinical Research papers must have no more than 5 figures and tables in total (e.g., 1 figure consisting of panels A and B,
and 4 tables). Authors are encouraged to include additional figures and tables as supplementary appendixes, and these will be considered
for Web-only publication.
c) Fast-track submission. For new findings of sufficient importance to justify accelerated
review and publication, a fast-track submission process for original articles is available. In the submission letter, authors should
explicitly request this option and provide credit card information (number, expiration date, name as it appears on the card, related
invoice address and email address). If the editors agree that the manuscript is worthy of fast-track publication, the fee of 600 Euros
will be automatically charged to the credit card. If accepted for fast-track submission, an article will be reviewed within 72 hours
(otherwise, authors will be informed that the paper will be handled within the normal peer-review process). If accepted, a fast-track
submission will appear in the first available issue of the journal.
PLEASE SELECT THE "FAST TRACK" OPTION FROM THE DROP DOWN MENU
OF PAPER TYPES WHEN YOU SUBMIT YOUR MANUSCRIPT.
d) Rapid
Communications. These papers should provide a brief but complete account of important new observations which merit urgent publication.
The papers should be less than 5 printed pages (8-10 double-spaced typed pages) including figures and tables and should be concisely
but adequately referenced. Authors should state in the comments section during the submission process why the paper merits urgent publication.
Papers requiring revision will not be considered as Rapid Communications. The Editor-in-Chief will normally reach a decision on these
papers within one month.
e) Short Communications. These papers should include original data of basic or clinical research.
The following word limits apply: abstract 150 words, main text 1500 words, up to 2 figures and or tables and a maximum of 15 references.
Authors maybe invited to submit a short communication by the editorial team.
f) Review Articles and Mini-Reviews, usually
by invitation. Mini-Reviews should normally consist of current short reviews of topical information. Word limit: 3500, 25 references
and up to 3 tables and or figures. Full reviews may contain up to 6 tables and or figures, authors are encouraged to include a "mechanism/overview"
figure. Word limit 5000 and 60 references. Exceptions to these limits should be discussed with the Reviews Editor before submission.
All Reviews should be submitted for handling by the Reviews Editor, Arnold von Eckardstein.
g) Hypotheses and Viewpoints
of up to 1500 words are published occasionally. These contributions are subject to the normal editorial procedure. These should be submitted
to the Editor-in-Chief.
h) Commentary. If you wish to comment on work published in Atherosclerosis, please submit your opinions
as a Commentary. The original Author(s) will have the opportunity to respond to your comments in the same issue of the journal.
i) Letters to the Editor are welcomed. Letters to the Editor reporting research findings that do not include novel data are
unlikely to be published. Letters should not exceed 1200 words and should be submitted to the Editor-in-Chief.
j) Announcements
of meetings, workshops, courses etc. are welcomed subject to available space.
Correspondence
Correspondence can be sent to the Editor-in-Chief:
Professor Steve Humphries
Cardiovascular Genetics
University
College London
Medical School, Rayne Institute
5 University Street
London WC1 E6JJ
UK
Fax: +44 20 7679 6212
E-mail: rmhasle@ucl.ac.uk
Reviews Editor: Arnold von Eckardstein (arnold.voneckardstein@ikc.usz.ch) Supplements
Editor: Steve Humphries (rmhasle@ucl.ac.uk) To ensure fast and efficient correspondence, all Authors must provide recent
e-mail addresses. Authors must submit the names, addresses, email addresses and phone/fax numbers of four potential reviewers.
Ethics in Publishing
For information
on Ethics in Publishing and Ethical guidelines for journal publication see http://www.elsevier.com/publishingethics and
http://www.elsevier.com/ethicalguidelines.
Conflict of interest
All
authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships
with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived
to influence, their work. See also http://www.elsevier.com/conflictsofinterest.
Patient Consent
Studies on patients or volunteers require ethics committee approval and informed consent which should
be documented in your paper.
Patients have a right to privacy. Therefore identifying information, including patients? images, names,
initials, or hospital numbers, should not be included in videos, recordings, written descriptions, photographs, and pedigrees unless
the information is essential for scientific purposes and you have obtained written informed consent for publication in print and electronic
form from the patient (or parent, guardian or next of kin where applicable). If such consent is made subject to any conditions, Elsevier
must be made aware of all such conditions. Written consents must be provided to Elsevier on request.
Even where consent has been
given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity,
such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should
so note. If such consent has not been obtained, personal details of patients included in any part of the paper and in any supplementary
materials (including all illustrations and videos) must be removed before submission.
Submission declaration
Submission of an article implies that the work described has not been published previously (except
in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication
elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was
carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any
other language, without the written consent of the copyright-holder.
Atherosclerosis will not tolerate plagiarism in submitted manuscripts. Passages quoted or closely paraphrased from other
authors (or from the submitting author's own published work) must be identified as quotations or paraphrases and sources quoted or paraphrased
material must be acknowledged. Use of unacknowledged sources will be construed as plagiarism. If any manuscript is found to contain plagiarised
material the review process will be halted immediately, and the University or Institute of the corresponding Author will be informed.
Atherosclerosis will not tolerate manipulation or enhancement of data. Authors will be asked to provide further evidence
for the validity of data, and the University or Institute of the corresponding Author will be informed if such evidence is not forthcoming.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement'
(for more information on this and copyright see http://www.elsevier.com/copyright). Acceptance of the agreement will ensure
the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript
together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce
tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of
the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations
and translations (please consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included,
the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted
forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details
you are referred to: http://www.elsevier.com/authorsrights.
Role of the
funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation
of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation
of data; in the writing of the report; and in the decision to submit the paper for publication. If the funding source(s) had no such
involvement then this should be stated. Please see http://www.elsevier.com/funding.
Funding Body Agreements
Elsevier has established agreements and developed policies to allow authors whose articles appear
in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant
awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies.
Submission Address
Atherosclerosis is a fully electronic journal, all manuscripts are to be submitted
via the internet.
To submit your paper online, click on the link http://ees.elsevier.com/ath/. This will take
you to the Atherosclerosis Editorial Manager home page. The Author Information box to the right of the page provides
relevant information, including a tutorial on how to submit your manuscript.
Manuscripts
Original articles should report original research not previously
published or being considered for publication elsewhere. Please note, suspected cases of plagiarism or manipulation of data will
be dealt with in consultation with the communicating author and the relevant authorities (please see below). Manuscripts should be written
in the English language (using either American or British spelling).
The number of words per manuscript should not exceed 4000 (including
tables and legends to figures).
As a rule, research papers should be divided into sections, headed by a caption (e.g. Abstract, Introduction,
Materials, Methods, Experimental Results, Discussion, etc.).
Please include a short paragraph of conclusions (at the end of the text),
indicating the relevance of the study with regard to the basics and/or clinical aspect of atherosclerosis. A statement concerning the
source of funding, conflicts of interests and disclosures of financial support is highly recommended.
Essential title page information
•
Title.
Concise and informative. Titles are often
used in information-retrieval systems. Avoid abbreviations and formulae where possible.
•
Author names and affiliations.
Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses
(where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the
author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name,
and, if available, the e-mail address of each author.
•
Corresponding author.
Clearly indicate who will handle
correspondence at all stages of refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with country
and area code) are provided in addition to the e-mail address and the complete postal address.
•
Present/permanent
address.
If an author has moved since the work described in the article was done, or was visiting at the time, a "Present address"
(or "Permanent address") may be indicated as a footnote to that author's name. The address at which the author actually did the work
must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstracts
A structured abstract (objective, methods, results and conclusion) of 50-250 words must be included.
Keywords
A keyword summary must be provided; normally 3-7 items should be included. Authors are encouraged
to choose their own keywords but, if in grave doubt which items to select, Medical Subject Headings (issued with the January Index Medicus, 1969) may be used as a guideline.
Tables
Tables
with titles and legends must be on separate pages with double spacing. Authors must list on the title page or in the covering e-mail,
the number of figures and/or tables to be found in the paper.
References
References must be given at the end of the paper, numbered in the order in which they appear in the text and quoted in the text
at appropriate places. The number of references must not exceed 30 (except for Reviews).
They should be arranged as follows: Authors
(second name and initial of first name(s), e.g. Mailhac A, Badimon JJ), title of article (upper case only on first word or proper nouns/names),
title of journal (standard abbreviation if possible), year of publication, volume number of journal and page range (e.g. 1432-6).
References
to books should include: Author's and/or Editor's name(s), title of book, place of publication, publisher, year, page numbers (if necessary).
This journal should be cited as Atherosclerosis.
DNA sequences and GenBank accession numbers
For each and every gene
accession number cited in an article, Authors must type the accession number in
bold underlined
text. Letters in the accession
number must always be capitalised.
Example: (GenBank accession nos.
AI631510
,
AI631511
,
AI632198
, and
BF223228
), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no.
BE675048
), and
a T-cell lymphoma (GenBank accession no.
AA361117
).
For all gene variants the rs number must be provided. Current
standard nomenclature for designation of DNA sequence variants must be adhered to: http://www.hgvs.org. In order to allow
for the work to be reproduced by others, where not previously published, authors are encouraged to provide as supplementary material
for web-publication only, the primers and PCR conditions for all variants genotyped in the manuscript.
Supplementary Data
Elsevier accepts electronic supplementary material (e-components) to support and enhance
presentation of your scientific research. Supplementary files offer the Author additional possibilities to publish supporting applications,
movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be
published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com.
In order to ensure that your submitted material is directly usable, please ensure that data is provided in one of our recommended file
formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption
for each file. For more detailed instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
Electronic artwork
General points
• Make sure you use uniform lettering and sizing
of your original artwork.
• Save text in illustrations as "graphics" or enclose the font.
• Only use the following
fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
•
Produce images near to the desired size of the printed version.
• Submit each figure as a separate file.
A detailed guide
on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged
to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application
used, when your electronic artwork is finalised, please "save as" or convert the images to one of the following formats (note the resolution
requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save
the text as "graphics".
TIFF: color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line
drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications please supply "as is".
Please
do not:
• Supply embedded graphics in your wordprocessor (spreadsheet, presentation) document;
• Supply files that
are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Colour
Illustrations
Colour illustrations online
Please make sure that artwork files are in an acceptable format (TIFF,
EPS or MS Office files) and with the correct resolution. Polaroid colour prints are not suitable. If, together with your accepted article,
you submit usable colour figures then Elsevier will ensure, at no additional charge, that these figures will appear in colour on the
Web (e.g. ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in colour in the printed version.
For colour reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article.
Please indicate your preference for colour in print or on the Web only. For further information on the preparation of electronic artwork,
please see http://authors.elsevier.com/artwork.
Please note: Because of technical complications which can arise by
converting colour figures to "grey scale" (for the printed version should you not opt for colour in print) please submit in addition
usable black and white versions of all the colour illustrations.
Submission checklist
It is hoped that this list will be useful during the final checking of an article prior to sending it to the journal's Editor
for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One Author designated as corresponding Author:
• E-mail address
• Full postal address
• Telephone and
fax numbers
All necessary files have been uploaded
• Keywords
• All figure captions
• All tables (including
title, description, footnotes)
Further considerations
• Manuscript has been "spellchecked" and "grammar-checked"
•
References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text,
and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Web)
•
Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print or to be reproduced
in color on the Web (free of charge) and in black-and-white in print
• If only color on the Web is required, black and white
versions of the figures are also supplied for printing purposes
For any further information please visit our customer support site
at http://epsupport.elsevier.com..
Use of the Digital Object Identifier
The Digital
Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string
which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore,
it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic
information. The correct format for citing a DOI is shown as follows (example taken from a document in the journal Physics Letters
B):
doi:10.1016/j.physletb.2003.10.071
When you use the DOI to create URL hyperlinks to documents on the web, they are guaranteed
never to change.
Proofs
Elsevier will do everything possible to get your
article corrected and published as quickly and accurately as possible. Therefore, it is important to ensure that all of your corrections
are sent back to us in one communication. Subsequent corrections will not be possible, so please ensure your first sending is complete.
Reprints
PDF offprints are provided free of charge. No reprints are provided free of charge. Reprints (50
copies minimum) can be ordered at quoted prices on order forms sent out together with the proofs.
For inquiries relating to the submission of articles (including electronic submission where available)
please visit this journal's homepage. You can track accepted articles at http://www.elsevier.com/trackarticle and set
up e-mail alerts to inform you of when an article's status has changed. Also accessible from here is information on copyright, frequently
asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs,
will be provided by the publisher.
|
| |
|
